The novel role and underlying mechanism of Wnt5a in regulating cellular cholesterol accumulation

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 9, 2014, Pages 671-678

  Qin, Li ^a,b   Hu, Rong ^b   Zhu, Neng ^c,d   Yao, Hai Lun ^b   Lei, Xiao Yong ^b   Li, Shun Xiang ^a   Liao, Duan Fang ^a   Zheng, Xi Long ^a,e  

^a HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

^b South University   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d THE SECOND AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

ATP binding cassette transporter A1 (ABCA1); Caveolin 1; Cholesterol accumulation; Wnt5a

Indexed keywords

ABC TRANSPORTER A1; CAVEOLIN 1; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; RAW 2647; UNCLASSIFIED DRUG; WNT5A PROTEIN; SMALL INTERFERING RNA; WNT PROTEIN; WNT5A PROTEIN, MOUSE;

ARTICLE; ATHEROSCLEROSIS; CELLS BY BODY ANATOMY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; DOWN REGULATION; DRUG EFFECT; DRUG POTENCY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; LIPID STORAGE; MACROPHAGE; POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MOUSE; RAT; WNT SIGNALING PATHWAY;

ANIMALS; ATHEROSCLEROSIS; ATP BINDING CASSETTE TRANSPORTER 1; CAVEOLIN 1; CELLS, CULTURED; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; LIPOPROTEINS, LDL; MALE; MICE; RATS; RNA, SMALL INTERFERING; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84911119164     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12258     Document Type: Article

References (31)

1. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473: 317-25.
2. Rosenson RS, Brewer HB Jr, Davidson WS et al. Cholesterol efflux and atheroprotection: Advancing the concept of reverse cholesterol transport. Circulation 2012; 125: 1905-19.
3. Kikuchi A, Yamamoto H, Sato A, Matsumoto S. Wnt5a: Its signalling, functions and implication in diseases. Acta Physiol. 2012; 204: 17-33.
4. Christman MA 2nd, Goetz DJ, Dickerson E et al. Wnt5a is expressed in murine and human atherosclerotic lesions. Am. J. Physiol. Heart Circ. Physiol. 2008; 294: H2864-70.
5. Kuo CY, Lin YC, Yang JJ, Yang VC. Interaction abolishment between mutant caveolin-1 ({up triangle, open}62-100) and ABCA1 reduces HDL-mediated cellular cholesterol efflux. Biochem. Biophys. Res. Commun. 2011; 414: 337-43.
6. Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell 2001; 104: 503-16.
7. Zhou Q, Mei Y, Shoji T et al. Rho-associated coiled-coil-containing kinase 2 deficiency in bone marrow-derived cells leads to increased cholesterol efflux and decreased atherosclerosis. Circulation 2012; 126: 2236-47.
8. Ouimet M, Marcel YL. Regulation of lipid droplet cholesterol efflux from macrophage foam cells. Arterioscler. Thromb. Vasc. Biol. 2012; 32: 575-81.
9. Kim J, Kim DW, Ha Y et al. Wnt5a induces endothelial inflammation via beta-catenin-independent signaling. J. Immunol. 2010; 185: 1274-82.
10. Schaale K, Neumann J, Schneider D, Ehlers S, Reiling N. Wnt signaling in macrophages: Augmenting and inhibiting mycobacteria-induced inflammatory responses. Eur. J. Cell Biol. 2011; 90: 553-9.
11. Terrand J, Bruban V, Zhou L et al. LRP1 controls intracellular cholesterol storage and fatty acid synthesis through modulation of Wnt signaling. J. Biol. Chem. 2009; 284: 381-8.
12. Masckauchan TN, Agalliu D, Vorontchikhina M et al. Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2. Mol. Biol. Cell 2006; 17: 5163-72.
13. Yin K, Liao DF, Tang CK. ATP-binding membrane cassette transporter A1 (ABCA1): A possible link between inflammation and reverse cholesterol transport. Mol. Med. 2010; 16: 438-49.
14. Fitzgerald ML, Mujawar Z, Tamehiro N. ABC transporters, atherosclerosis and inflammation. Atherosclerosis 2010; 211: 361-70.
15. Aiello RJ, Brees D, Francone OL. ABCA1-deficient mice: Insights into the role of monocyte lipid efflux in HDL formation and inflammation. Arterioscler. Thromb. Vasc. Biol. 2003; 23: 972-80.
16. Tang C, Liu Y, Kessler PS, Vaughan AM, Oram JF. The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. J. Biol. Chem. 2009; 284: 336-43.
17. Vaisman BL, Demosky SJ, Stonik JA et al. Endothelial expression of human ABCA1 in mice increases plasma HDL cholesterol and reduces diet-induced atherosclerosis. J. Lipid Res. 2012; 53: 158-67.
18. Hansen C, Howlin J, Tengholm A et al. Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner. J. Biol. Chem. 2009; 284: 533-43.
19. Hu YW, Ma X, Li XX et al. Eicosapentaenoic acid reduces ABCA1 serine phosphorylation and impairs ABCA1-dependent cholesterol efflux through cyclic AMP/protein kinase A signaling pathway in THP-1 macrophage-derived foam cells. Atherosclerosis 2009; 204: e35-43.
20. Katoh M. WNT signaling in stem cell biology and regenerative medicine. Curr. Drug Targets 2008; 9: 565-70.
21. Pavlides S, Gutierrez-Pajares JL, Danilo C, Lisanti MP, Frank PG. Atherosclerosis, caveolae and caveolin-1. Adv. Exp. Med. Biol. 2012; 729: 127-44.
22. Fielding CJ, Fielding PE. Caveolae and intracellular trafficking of cholesterol. Adv. Drug Deliv. Rev. 2001; 49: 251-64.
23. Sun SW, Zu XY, Tuo QH et al. Caveolae and caveolin-1 mediate endocytosis and transcytosis of oxidized low density lipoprotein in endothelial cells. Acta Pharmacol. Sin. 2010; 31: 1336-42.
24. Uittenbogaard A, Smart EJ. Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation, and rapid transport of cholesterol to caveolae. J. Biol. Chem. 2000; 275: 595-9.
25. Feig JE, Hewing B, Smith JD, Hazen SL, Fisher EA. High-density lipoprotein and atherosclerosis regression: Evidence from preclinical and clinical studies. Circ. Res. 2014; 114: 205-13.
26. Li G, Gu HM, Zhang DW. ATP-binding cassette transporters and cholesterol translocation. IUBMB Life 2013; 65: 505-12.
27. Luo DX, Cao DL, Xiong Y, Peng XH, Liao DF. A novel model of cholesterol efflux from lipid-loaded cells. Acta Pharmacol. Sin. 2010; 31: 1243-57.
28. Qin L, Zhang X, Zhang L et al. Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells. Biochem. Biophys. Res. Commun. 2008; 371: 531-5.
29. Yang M, Huang HL, Zhu BY, Tuo QH, Liao DF. Onychin inhibits proliferation of vascular smooth muscle cells by regulating cell cycle. Acta Pharmacol. Sin. 2005; 26: 205-11.
30. Luo DX, Xia CL, Li JM et al. Static pressure accelerates ox-LDL-induced cholesterol accumulation via SREBP-1-mediated caveolin-1 downregulation in cultured vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 2010; 403: 52-8.
31. Qin L, Yang YB, Tuo QH et al. Effects and underlying mechanisms of curcumin on the proliferation of vascular smooth muscle cells induced by Chol:MβCD. Biochem. Biophys. Res. Commun. 2009; 379: 277-82.